Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

E

EGBOT

Guest
Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

HTML:
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.

Source: Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Latest threads

Back
Top